simendan has been researched along with Tetralogy of Fallot in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dosta-Herrera, JJ; Gutiérrez-Riveroll, KI; Mejía Picazo, HJ | 1 |
Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H | 1 |
2 trial(s) available for simendan and Tetralogy of Fallot
Article | Year |
---|---|
[Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot].
Topics: Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hydrazones; Longitudinal Studies; Milrinone; Prospective Studies; Pyridazines; Simendan; Syndrome; Tetralogy of Fallot | 2022 |
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Creatinine; Double-Blind Method; Female; Finland; Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Ventricular; Humans; Infant; Male; Milrinone; Prospective Studies; Simendan; Sweden; Tetralogy of Fallot | 2019 |